In case you missed it: July 25 to July 29


A look back at this week's news.

Placental cord drainage may be simpler, more effective than standard practice

Placental cord drainage may be the key to managing the third stage of labor, according to research in BMC Pregnancy and Childbirth.

RVVC treatment drug oteseconazole now commercially available in US

Mycovia Pharmaceuticals recently announced US availability of oteseconazole capsules for the treatment of recurrent vulvovaginal candidiasis in women without reproductive potential.

Fezolinetant making waves for VMS

Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).

Clinical considerations for monkeypox in pregnancy

What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.

COVID-19 pregnancy data in the United States: July 25 update

Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.

ObsEva drops linzagolix, focuses on prospects for preterm labor, IVF

ObsEva plans to drop linzagolix, its leading candidate for the treatment of uterine fibroids, following concerns raised by the FDA.

Related Videos
Fezolinetant effective against vasomotor symptoms | Image Credit:
Discussing PCOS: misconceptions, management, encouragement | Image Credit:
The importance of diversity in obstetrics | Image Credit: ©
Study confirms efficacy of JADA against postpartum bleeding | Image Credit: © Amy Taneja MD - © Amy Taneja MD -
Matthew Zerden, MD
John Stanley, MD
Marci Bowers, MD | Image Credit:
Related Content
© 2023 MJH Life Sciences

All rights reserved.